Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer

Clinical trial NCT00673049 · TERMINATED

Trial details

NCT number: NCT00673049
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Large Cell Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Carcinoma, Adenosquamous Cell

Start date: 2008-05-01
Primary completion: 2011-03-01
Enrollment: 583

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.